Genetic Signatures Ltd GSS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.68
- Day Range
- A$0.68–0.68
- 52-Week Range
- A$0.38–0.76
- Bid/Ask
- A$0.68 / A$0.68
- Market Cap
- A$126.81 Mil
- Volume/Avg
- 75,859 / 135,544
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 6.79
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Genetic Signatures Ltd proprietary PCR solutions and automated workflows routinely screen for multiple infectious diseases in a single test. Rapid and accurate results facilitate improved patient management and healthcare outcomes. GSS continues to expand its global reach with direct representation in Australia, Europe, and the United States, and growing distribution partnerships. The company operates under one business segment which is the research and commercialisation of identifying individual genetic signatures to diagnose diseases and disabilities.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- —
Comparables
Valuation
|
Metric
|
GSS
|
084650
|
300685
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 44.60 |
Price/Book Value | 3.13 | 0.89 | 5.30 |
Price/Sales | 6.79 | 2.77 | 8.76 |
Price/Cash Flow | — | 167.49 | 31.01 |
Price/Earnings
GSS
084650
300685
Financial Strength
|
Metric
|
GSS
|
084650
|
300685
|
|---|---|---|---|
Quick Ratio | 5.34 | 2.38 | 13.42 |
Current Ratio | 8.06 | 2.47 | 13.97 |
Interest Coverage | — | −1.33 | 194.63 |
Quick Ratio
GSS
084650
300685
Profitability
|
Metric
|
GSS
|
084650
|
300685
|
|---|---|---|---|
Return on Assets (Normalized) | −35.48% | 1.86% | 11.25% |
Return on Equity (Normalized) | −39.39% | 2.42% | 12.34% |
Return on Invested Capital (Normalized) | −40.51% | 2.00% | 12.20% |
Return on Assets
GSS
084650
300685
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Wllzkrmzg | Jqd | $209.3 Bil | |
DHR
| Danaher Corp | Xjhhqtdbj | Qthhnp | $174.8 Bil | |
IQV
| IQVIA Holdings Inc | Lphhvjjzf | Tvcrpn | $43.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Ckgvxpzps | Szmjlr | $41.0 Bil | |
A
| Agilent Technologies Inc | Jbqzwvpd | Tjbr | $39.2 Bil | |
MTD
| Mettler-Toledo International Inc | Zkpkzvcqn | Dkqmbr | $26.5 Bil | |
ICLR
| Icon PLC | Gxpsqtm | Czwjch | $25.2 Bil | |
ILMN
| Illumina Inc | Rrnpkrw | Cggdkvd | $19.8 Bil | |
WAT
| Waters Corp | Gdmbfldyxy | Gvwl | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Mygblbmpl | Yhrysx | $17.1 Bil |